Biotechnology
Compare Stocks
5 / 10Stock Comparison
CBUS vs PGEN vs RKDA vs SEED vs APLD
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Agricultural Inputs
Agricultural Inputs
Information Technology Services
CBUS vs PGEN vs RKDA vs SEED vs APLD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Biotechnology | Biotechnology | Agricultural Inputs | Agricultural Inputs | Information Technology Services |
| Market Cap | $686M | $1.22B | $2M | $9M | $11.89B |
| Revenue (TTM) | $4M | $6M | $5M | $102M | $282M |
| Net Income (TTM) | $-127M | $-247M | $-2M | $-43M | $-123M |
| Gross Margin | 23.9% | 23.0% | 36.2% | 5.5% | 16.4% |
| Operating Margin | -26.8% | -18.6% | -51.4% | -72.6% | -31.5% |
| Total Debt | $33M | $6M | $0.00 | $54M | $703M |
| Cash & Equiv. | $10M | $30M | $259K | $16M | $114M |
CBUS vs PGEN vs RKDA vs SEED vs APLD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 22 | May 26 | Return |
|---|---|---|---|
| Cibus, Inc. (CBUS) | 100 | 6.8 | -93.2% |
| Precigen, Inc. (PGEN) | 100 | 312.0 | +212.0% |
| Arcadia Biosciences… (RKDA) | 100 | 2.8 | -97.2% |
| Origin Agritech Lim… (SEED) | 100 | 12.8 | -87.2% |
| Applied Digital Cor… (APLD) | 100 | 1236.0 | +1136.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBUS vs PGEN vs RKDA vs SEED vs APLD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBUS plays a supporting role in this comparison — it may shine differently against other peers.
PGEN is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.44, Low D/E 14.3%, current ratio 4.76x
RKDA is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 0.98
- Beta 0.98, current ratio 3.09x
SEED is the #2 pick in this set and the best alternative if quality and stability is your priority.
- -42.6% margin vs PGEN's -39.1%
- Beta 0.94 vs APLD's 3.23
APLD carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 57.7%, EPS growth 11.5%, 3Y rev CAGR 193.2%
- 7.6% 10Y total return vs PGEN's -84.6%
- 57.7% revenue growth vs PGEN's -36.9%
- 0.0% yield; 1-year raise streak; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 57.7% revenue growth vs PGEN's -36.9% | |
| Quality / Margins | -42.6% margin vs PGEN's -39.1% | |
| Stability / Safety | Beta 0.94 vs APLD's 3.23 | |
| Dividends | 0.0% yield; 1-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +6.9% vs RKDA's -74.4% | |
| Efficiency (ROA) | -2.3% ROA vs PGEN's -144.1%, ROIC -7.3% vs -152.8% |
CBUS vs PGEN vs RKDA vs SEED vs APLD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBUS vs PGEN vs RKDA vs SEED vs APLD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
APLD leads in 2 of 6 categories
RKDA leads 1 • CBUS leads 0 • PGEN leads 0 • SEED leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SEED and APLD each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
APLD is the larger business by revenue, generating $282M annually — 77.4x CBUS's $4M. Profitability is closely matched — net margins range from -42.6% (SEED) to -39.1% (PGEN). On growth, PGEN holds the edge at +2.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4M | $6M | $5M | $102M | $282M |
| EBITDAEarnings before interest/tax | -$92M | -$115M | -$2M | -$74M | -$53M |
| Net IncomeAfter-tax profit | -$127M | -$247M | -$2M | -$43M | -$123M |
| Free Cash FlowCash after capex | -$51M | -$76M | -$5M | -$40M | -$1.3B |
| Gross MarginGross profit ÷ Revenue | +23.9% | +23.0% | +36.2% | +5.5% | +16.4% |
| Operating MarginEBIT ÷ Revenue | -26.8% | -18.6% | -51.4% | -72.6% | -31.5% |
| Net MarginNet income ÷ Revenue | -34.9% | -39.1% | -48.1% | -42.6% | -43.5% |
| FCF MarginFCF ÷ Revenue | -14.1% | -12.0% | -97.6% | -39.0% | -4.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -12.8% | +2.1% | -25.9% | +75.7% | +98.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +55.2% | -11.7% | +16.9% | -3.4% | +89.4% |
Valuation Metrics
RKDA leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $686M | $1.2B | $2M | $9M | $11.9B |
| Enterprise ValueMkt cap + debt − cash | $709M | $1.2B | $1M | $14M | $12.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.54x | -8.83x | -0.64x | -1.10x | -35.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | — | 1099.67x |
| Price / SalesMarket cap ÷ Revenue | 188.61x | 309.66x | 0.31x | 0.64x | 55.16x |
| Price / BookPrice ÷ Book value/share | 31.44x | 28.85x | 0.36x | — | 13.18x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | — |
Profitability & Efficiency
APLD leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
APLD delivers a -6.2% return on equity — every $100 of shareholder capital generates $-6 in annual profit, vs $-6 for PGEN. PGEN carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to CBUS's 1.51x. On the Piotroski fundamental quality scale (0–9), PGEN scores 3/9 vs SEED's 2/9, reflecting mixed financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.3% | -5.9% | -40.6% | — | -6.2% |
| ROA (TTM)Return on assets | -38.6% | -144.1% | -26.1% | -42.3% | -2.3% |
| ROICReturn on invested capital | -61.5% | -152.8% | -2.5% | — | -7.3% |
| ROCEReturn on capital employed | -21.8% | -107.2% | -129.5% | — | -9.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 | 2 | 2 | 3 |
| Debt / EquityFinancial leverage | 1.51x | 0.14x | — | — | 1.11x |
| Net DebtTotal debt minus cash | $23M | -$24M | -$259,000 | $38M | $589M |
| Cash & Equiv.Liquid assets | $10M | $30M | $259,000 | $16M | $114M |
| Total DebtShort + long-term debt | $33M | $6M | $0 | $54M | $703M |
| Interest CoverageEBIT ÷ Interest expense | -2.49x | -273.83x | — | -23.25x | -2.01x |
Total Returns (Dividends Reinvested)
APLD leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in APLD five years ago would be worth $85,629 today (with dividends reinvested), compared to $69 for CBUS. Over the past 12 months, APLD leads with a +691.0% total return vs RKDA's -74.4%. The 3-year compound annual growth rate (CAGR) favors APLD at 130.5% vs CBUS's -54.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -20.2% | -3.0% | -48.8% | -1.7% | +47.7% |
| 1-Year ReturnPast 12 months | -40.0% | +207.4% | -74.4% | -1.7% | +691.0% |
| 3-Year ReturnCumulative with dividends | -90.5% | +232.0% | -82.8% | -81.7% | +1125.1% |
| 5-Year ReturnCumulative with dividends | -99.3% | -36.5% | -98.9% | -91.4% | +756.3% |
| 10-Year ReturnCumulative with dividends | -99.7% | -84.6% | -99.9% | -93.2% | +756.3% |
| CAGR (3Y)Annualised 3-year return | -54.4% | +49.2% | -44.4% | -43.2% | +130.5% |
Risk & Volatility
Evenly matched — SEED and APLD each lead in 1 of 2 comparable metrics.
Risk & Volatility
SEED is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than APLD's 3.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APLD currently trades 93.9% from its 52-week high vs RKDA's 16.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.12x | 1.44x | 0.98x | 0.94x | 3.23x |
| 52-Week HighHighest price in past year | $4.19 | $5.23 | $6.71 | $2.49 | $44.22 |
| 52-Week LowLowest price in past year | $1.09 | $1.23 | $1.01 | $0.74 | $5.09 |
| % of 52W HighCurrent price vs 52-week peak | +35.8% | +79.3% | +16.4% | +45.8% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 62.7 | 42.3 | 43.9 | 74.4 |
| Avg Volume (50D)Average daily shares traded | 603K | 4.3M | 35K | 93K | 20.3M |
Analyst Outlook
Evenly matched — CBUS and RKDA and APLD each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CBUS as "Buy", PGEN as "Buy", APLD as "Buy". Consensus price targets imply 666.7% upside for CBUS (target: $12) vs 44.6% for PGEN (target: $6).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | — | — | Buy |
| Price TargetConsensus 12-month target | $11.50 | $6.00 | — | — | $61.00 |
| # AnalystsCovering analysts | 4 | 16 | — | — | 13 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.0% |
| Dividend StreakConsecutive years of raises | 1 | — | 1 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — | $0.01 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | +0.3% |
APLD leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). RKDA leads in 1 (Valuation Metrics). 3 tied.
CBUS vs PGEN vs RKDA vs SEED vs APLD: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is CBUS or PGEN or RKDA or SEED or APLD a better buy right now?
For growth investors, Applied Digital Corporation (APLD) is the stronger pick with 57.
7% revenue growth year-over-year, versus -36. 9% for Precigen, Inc. (PGEN). Analysts rate Cibus, Inc. (CBUS) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CBUS or PGEN or RKDA or SEED or APLD?
Over the past 5 years, Applied Digital Corporation (APLD) delivered a total return of +756.
3%, compared to -99. 3% for Cibus, Inc. (CBUS). Over 10 years, the gap is even starker: APLD returned +756. 3% versus RKDA's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CBUS or PGEN or RKDA or SEED or APLD?
By beta (market sensitivity over 5 years), Origin Agritech Limited (SEED) is the lower-risk stock at 0.
94β versus Applied Digital Corporation's 3. 23β — meaning APLD is approximately 245% more volatile than SEED relative to the S&P 500. On balance sheet safety, Precigen, Inc. (PGEN) carries a lower debt/equity ratio of 14% versus 151% for Cibus, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — CBUS or PGEN or RKDA or SEED or APLD?
By revenue growth (latest reported year), Applied Digital Corporation (APLD) is pulling ahead at 57.
7% versus -36. 9% for Precigen, Inc. (PGEN). On earnings-per-share growth, the picture is similar: Cibus, Inc. grew EPS 74. 3% year-over-year, compared to -319. 7% for Origin Agritech Limited. Over a 3-year CAGR, APLD leads at 193. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CBUS or PGEN or RKDA or SEED or APLD?
Arcadia Biosciences, Inc.
(RKDA) is the more profitable company, earning -48. 1% net margin versus -34. 9% for Cibus, Inc. — meaning it keeps -48. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: APLD leads at -33. 5% versus -34. 4% for PGEN. At the gross margin level — before operating expenses — RKDA leads at 36. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CBUS or PGEN or RKDA or SEED or APLD?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is CBUS or PGEN or RKDA or SEED or APLD better for a retirement portfolio?
For long-horizon retirement investors, Origin Agritech Limited (SEED) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
94)). Cibus, Inc. (CBUS) carries a higher beta of 3. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SEED: -93. 2%, CBUS: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CBUS and PGEN and RKDA and SEED and APLD?
These companies operate in different sectors (CBUS (Healthcare) and PGEN (Healthcare) and RKDA (Basic Materials) and SEED (Basic Materials) and APLD (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CBUS is a small-cap quality compounder stock; PGEN is a small-cap quality compounder stock; RKDA is a small-cap quality compounder stock; SEED is a small-cap quality compounder stock; APLD is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.